The COVID‐19 pandemic: Key considerations for the epidemic and its control

The response to the ongoing COVID‐19 pandemic has been characterized by draconian measures and far too many important unknowns, such as the true mortality risk, the role of children as transmitters and the development and duration of immunity in the population. More than a year into the pandemic muc...

Full description

Bibliographic Details
Published in:APMIS
Main Authors: Ørskov, Søren, Frost Nielsen, Bjarke, Føns, Sofie, Sneppen, Kim, Simonsen, Lone
Format: Text
Language:English
Published: John Wiley and Sons Inc. 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239778/
http://www.ncbi.nlm.nih.gov/pubmed/33932317
https://doi.org/10.1111/apm.13141
id ftpubmed:oai:pubmedcentral.nih.gov:8239778
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8239778 2023-05-15T16:52:56+02:00 The COVID‐19 pandemic: Key considerations for the epidemic and its control Ørskov, Søren Frost Nielsen, Bjarke Føns, Sofie Sneppen, Kim Simonsen, Lone 2021-05-01 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239778/ http://www.ncbi.nlm.nih.gov/pubmed/33932317 https://doi.org/10.1111/apm.13141 en eng John Wiley and Sons Inc. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239778/ http://www.ncbi.nlm.nih.gov/pubmed/33932317 http://dx.doi.org/10.1111/apm.13141 This article is protected by copyright. All rights reserved. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. APMIS Original Articles Text 2021 ftpubmed https://doi.org/10.1111/apm.13141 2021-07-04T01:01:13Z The response to the ongoing COVID‐19 pandemic has been characterized by draconian measures and far too many important unknowns, such as the true mortality risk, the role of children as transmitters and the development and duration of immunity in the population. More than a year into the pandemic much has been learned and insights into this novel type of pandemic and options for control are shaping up. Using a historical lens, we review what we know and still do not know about the ongoing COVID‐19 pandemic. A pandemic caused by a member of the coronavirus family is a new situation following more than a century of influenza A pandemics. However, recent pandemic threats such as outbreaks of the related and novel deadly coronavirus SARS in 2003 and of MERS since 2012 had put coronaviruses on WHOs blueprint list of priority diseases. Like pandemic influenza, SARS‐CoV‐2 is highly transmissible (R(0) ~2.5). Furthermore, it can fly under the radar due to a broad clinical spectrum where asymptomatic and pre‐symptomatic infected persons also transmit the virus – including children. COVID‐19 is far more deadly than seasonal influenza; initial data from China suggested a case fatality rate of 2.3% – which would have been on par with the deadly 1918 Spanish influenza. But, while the Spanish influenza killed young, otherwise healthy adults, it is the elderly who are at extreme risk of dying of COVID‐19. We review available seroepidemiological evidence of infection rates and compute infection fatality rates (IFR) for Denmark (0.5%), Spain (0.85%) and Iceland (0.3%). We also deduce that population age structure is key. SARS‐CoV‐2 is characterized by superspreading, so that ~10% of infected individuals yield 80% of new infections. This phenomenon turns out to be an Achilles heel of the virus that may explain our ability to effectively mitigate outbreaks so far. How will this pandemic come to an end? Herd immunity has not been achieved in Europe due to intense mitigation by non‐pharmaceutical interventions; for example, only ~8% ... Text Iceland PubMed Central (PMC) Achilles Heel ENVELOPE(-63.596,-63.596,-64.500,-64.500) APMIS 129 7 408 420
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Original Articles
spellingShingle Original Articles
Ørskov, Søren
Frost Nielsen, Bjarke
Føns, Sofie
Sneppen, Kim
Simonsen, Lone
The COVID‐19 pandemic: Key considerations for the epidemic and its control
topic_facet Original Articles
description The response to the ongoing COVID‐19 pandemic has been characterized by draconian measures and far too many important unknowns, such as the true mortality risk, the role of children as transmitters and the development and duration of immunity in the population. More than a year into the pandemic much has been learned and insights into this novel type of pandemic and options for control are shaping up. Using a historical lens, we review what we know and still do not know about the ongoing COVID‐19 pandemic. A pandemic caused by a member of the coronavirus family is a new situation following more than a century of influenza A pandemics. However, recent pandemic threats such as outbreaks of the related and novel deadly coronavirus SARS in 2003 and of MERS since 2012 had put coronaviruses on WHOs blueprint list of priority diseases. Like pandemic influenza, SARS‐CoV‐2 is highly transmissible (R(0) ~2.5). Furthermore, it can fly under the radar due to a broad clinical spectrum where asymptomatic and pre‐symptomatic infected persons also transmit the virus – including children. COVID‐19 is far more deadly than seasonal influenza; initial data from China suggested a case fatality rate of 2.3% – which would have been on par with the deadly 1918 Spanish influenza. But, while the Spanish influenza killed young, otherwise healthy adults, it is the elderly who are at extreme risk of dying of COVID‐19. We review available seroepidemiological evidence of infection rates and compute infection fatality rates (IFR) for Denmark (0.5%), Spain (0.85%) and Iceland (0.3%). We also deduce that population age structure is key. SARS‐CoV‐2 is characterized by superspreading, so that ~10% of infected individuals yield 80% of new infections. This phenomenon turns out to be an Achilles heel of the virus that may explain our ability to effectively mitigate outbreaks so far. How will this pandemic come to an end? Herd immunity has not been achieved in Europe due to intense mitigation by non‐pharmaceutical interventions; for example, only ~8% ...
format Text
author Ørskov, Søren
Frost Nielsen, Bjarke
Føns, Sofie
Sneppen, Kim
Simonsen, Lone
author_facet Ørskov, Søren
Frost Nielsen, Bjarke
Føns, Sofie
Sneppen, Kim
Simonsen, Lone
author_sort Ørskov, Søren
title The COVID‐19 pandemic: Key considerations for the epidemic and its control
title_short The COVID‐19 pandemic: Key considerations for the epidemic and its control
title_full The COVID‐19 pandemic: Key considerations for the epidemic and its control
title_fullStr The COVID‐19 pandemic: Key considerations for the epidemic and its control
title_full_unstemmed The COVID‐19 pandemic: Key considerations for the epidemic and its control
title_sort covid‐19 pandemic: key considerations for the epidemic and its control
publisher John Wiley and Sons Inc.
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239778/
http://www.ncbi.nlm.nih.gov/pubmed/33932317
https://doi.org/10.1111/apm.13141
long_lat ENVELOPE(-63.596,-63.596,-64.500,-64.500)
geographic Achilles Heel
geographic_facet Achilles Heel
genre Iceland
genre_facet Iceland
op_source APMIS
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239778/
http://www.ncbi.nlm.nih.gov/pubmed/33932317
http://dx.doi.org/10.1111/apm.13141
op_rights This article is protected by copyright. All rights reserved.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
op_doi https://doi.org/10.1111/apm.13141
container_title APMIS
container_volume 129
container_issue 7
container_start_page 408
op_container_end_page 420
_version_ 1766043445788409856